Bridge City Capital, LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1713521 LAKE OSWEGO, OR

Position in CPRX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,854,859

+$197,878 QoQ

Shares Held

155,689

-0.6% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

1.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 55% Shared 0% None 45%

Healthcare · as of Mar 31, 2026

Bridge City Capital, LLC holds $13,944,831 across 5 Biotechnology names. CPRX ranks #1 (27.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc. This page	155,689	$3,854,859
2	KRYS	Krystal Biotech, Inc.	12,045	$3,111,464
3	TGTX	Tg Therapeutics, Inc.	90,634	$3,010,861
4	CORT	Corcept Therapeutics Inc	54,874	$2,211,970
5	VCEL	Vericel Corp	54,575	$1,755,677

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,854,859	155,689	-0.6%	Shares	Sole	2026-05-13
2025-12-31	$3,656,981	156,683	-14.1%	Shares	Sole	2026-02-13
2025-09-30	$3,591,231	182,296	+57.3%	Shares	Sole	2025-11-12
2025-06-30	$2,514,617	115,881	-1.3%	Shares	Sole	2025-08-13
2025-03-31	$2,846,319	117,374	—	Shares	Sole	2025-04-14
No filing history on record for this holder in this stock.